| Variables . | All (n = 58) . | HD (n = 46) . | PD (n = 12) . |
|---|---|---|---|
| Age | 67.0 (54.0–77.0) | 67.0 (54.0–77.0) | 66.5 (54.5–84.5) |
| Weight (kg) | 75 (62.0–87) | 75.3 (66.1–87.7) | 68.5 (52.0–85) |
| Men, n (%) | 45 (78) | 36 (78.) | 9 (75) |
| Caucasian, n (%) | 40 (70) | 31 (67) | 9 (75) |
| Diabetes, n (%) | 28 (48) | 24 (52) | 4 (33) |
| IHD, n (%) | 17 (29) | 14 (30) | 3 (25) |
| HT, n (%) | 51 (88) | 41 (89.1) | 10 (83) |
| Smoking, n (%) | 9 (16) | 9 (20) | 0 (0) |
| Statins, n (%) | 26 (45) | 25 (54) | 7 (58) |
| Aspirin,a n (%) | 27 (47) | 20 (44) | 7 (58) |
| Active vitamin D, n (%) | 12 (21) | 9 (20) | 3 (25) |
| Native vitamin D, n (%) | 34 (59) | 27 (59) | 7 (58) |
| Non-calcium phosphate binders, n (%) | 26 (45) | 23 (51) | 3 (25) |
| SBP (mmHg) | 138 (123–150) | 139 (126–151) | 136 (120–143) |
| DBP (mmHg) | 73 (65–85) | 73 (67–81) | 69.5 (61–89) |
| eGFR (mL/min/ 1.73 m2) | 9 (7–11) | 8 (7–10) | 10.5 (6–12) |
| Variables . | All (n = 58) . | HD (n = 46) . | PD (n = 12) . |
|---|---|---|---|
| Age | 67.0 (54.0–77.0) | 67.0 (54.0–77.0) | 66.5 (54.5–84.5) |
| Weight (kg) | 75 (62.0–87) | 75.3 (66.1–87.7) | 68.5 (52.0–85) |
| Men, n (%) | 45 (78) | 36 (78.) | 9 (75) |
| Caucasian, n (%) | 40 (70) | 31 (67) | 9 (75) |
| Diabetes, n (%) | 28 (48) | 24 (52) | 4 (33) |
| IHD, n (%) | 17 (29) | 14 (30) | 3 (25) |
| HT, n (%) | 51 (88) | 41 (89.1) | 10 (83) |
| Smoking, n (%) | 9 (16) | 9 (20) | 0 (0) |
| Statins, n (%) | 26 (45) | 25 (54) | 7 (58) |
| Aspirin,a n (%) | 27 (47) | 20 (44) | 7 (58) |
| Active vitamin D, n (%) | 12 (21) | 9 (20) | 3 (25) |
| Native vitamin D, n (%) | 34 (59) | 27 (59) | 7 (58) |
| Non-calcium phosphate binders, n (%) | 26 (45) | 23 (51) | 3 (25) |
| SBP (mmHg) | 138 (123–150) | 139 (126–151) | 136 (120–143) |
| DBP (mmHg) | 73 (65–85) | 73 (67–81) | 69.5 (61–89) |
| eGFR (mL/min/ 1.73 m2) | 9 (7–11) | 8 (7–10) | 10.5 (6–12) |
Values are presented as median (25th–75th quartile range) unless stated otherwise.
One was taking clopidogrel.
IHD, ischaemic heart disease; HT, hypertension; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate.
| Variables . | All (n = 58) . | HD (n = 46) . | PD (n = 12) . |
|---|---|---|---|
| Age | 67.0 (54.0–77.0) | 67.0 (54.0–77.0) | 66.5 (54.5–84.5) |
| Weight (kg) | 75 (62.0–87) | 75.3 (66.1–87.7) | 68.5 (52.0–85) |
| Men, n (%) | 45 (78) | 36 (78.) | 9 (75) |
| Caucasian, n (%) | 40 (70) | 31 (67) | 9 (75) |
| Diabetes, n (%) | 28 (48) | 24 (52) | 4 (33) |
| IHD, n (%) | 17 (29) | 14 (30) | 3 (25) |
| HT, n (%) | 51 (88) | 41 (89.1) | 10 (83) |
| Smoking, n (%) | 9 (16) | 9 (20) | 0 (0) |
| Statins, n (%) | 26 (45) | 25 (54) | 7 (58) |
| Aspirin,a n (%) | 27 (47) | 20 (44) | 7 (58) |
| Active vitamin D, n (%) | 12 (21) | 9 (20) | 3 (25) |
| Native vitamin D, n (%) | 34 (59) | 27 (59) | 7 (58) |
| Non-calcium phosphate binders, n (%) | 26 (45) | 23 (51) | 3 (25) |
| SBP (mmHg) | 138 (123–150) | 139 (126–151) | 136 (120–143) |
| DBP (mmHg) | 73 (65–85) | 73 (67–81) | 69.5 (61–89) |
| eGFR (mL/min/ 1.73 m2) | 9 (7–11) | 8 (7–10) | 10.5 (6–12) |
| Variables . | All (n = 58) . | HD (n = 46) . | PD (n = 12) . |
|---|---|---|---|
| Age | 67.0 (54.0–77.0) | 67.0 (54.0–77.0) | 66.5 (54.5–84.5) |
| Weight (kg) | 75 (62.0–87) | 75.3 (66.1–87.7) | 68.5 (52.0–85) |
| Men, n (%) | 45 (78) | 36 (78.) | 9 (75) |
| Caucasian, n (%) | 40 (70) | 31 (67) | 9 (75) |
| Diabetes, n (%) | 28 (48) | 24 (52) | 4 (33) |
| IHD, n (%) | 17 (29) | 14 (30) | 3 (25) |
| HT, n (%) | 51 (88) | 41 (89.1) | 10 (83) |
| Smoking, n (%) | 9 (16) | 9 (20) | 0 (0) |
| Statins, n (%) | 26 (45) | 25 (54) | 7 (58) |
| Aspirin,a n (%) | 27 (47) | 20 (44) | 7 (58) |
| Active vitamin D, n (%) | 12 (21) | 9 (20) | 3 (25) |
| Native vitamin D, n (%) | 34 (59) | 27 (59) | 7 (58) |
| Non-calcium phosphate binders, n (%) | 26 (45) | 23 (51) | 3 (25) |
| SBP (mmHg) | 138 (123–150) | 139 (126–151) | 136 (120–143) |
| DBP (mmHg) | 73 (65–85) | 73 (67–81) | 69.5 (61–89) |
| eGFR (mL/min/ 1.73 m2) | 9 (7–11) | 8 (7–10) | 10.5 (6–12) |
Values are presented as median (25th–75th quartile range) unless stated otherwise.
One was taking clopidogrel.
IHD, ischaemic heart disease; HT, hypertension; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
